Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

15 Biggest Mid-Day Losers For Friday

GRVY, AFMD, EFX, BIMI, HLF, GE, PLUR, CENN

  • Pluristem Therapeutics Inc. (NASDAQ: PSTI) shares dipped 22.9 percent to $1.08. Pluristem disclosed that it has increased its bought deal offering to $15 million of stock and warrants.
  • Affimed NV (NASDAQ: AFMD) shares fell 20.9 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.
  • Uranium Resources, Inc. (NASDAQ: URRE) dropped 14.6 percent to $2.29 after the company reported a closing of $9.7 million public offering.
  • NF Energy Saving Corp (NASDAQ: NFEC) shares fell 14 percent to $1.10. On Thursday, NF Energy Saving reported a business cooperation with an Indian company.
  • Naked Brand Group Inc (NASDAQ: NAKD) declined 13.7 percent to $1.83. Naked Brand shares have dropped 22.06 percent over the past 52 weeks, while the S&P 500 index has gained 21.75 percent in the same period.
  • Delta Technology Holdings Limited (NASDAQ: DELT) shares fell 13.3 percent to $1.50. On Thursday, Delta Technology posted a surge in sales for the fourth quarter.
  • Bristol-Myers Squibb Co (NYSE: BMY) shares declined 9.5 percent to $50.21 after the company reported that it will not be pursuing accelerated regulatory approval for its lung cancer drug Opvido/Yervoy.
  • Gravity Co., LTD. (ADR) (NASDAQ: GRVY) dropped 7.8 percent to $19.33 after rising 23.11 percent on Thursday.
  • Synergy Pharmaceuticals Inc (NASDAQ: SGYP) declined 6.7 percent to $5.98. The U.S. Food and Drug Administration said it approved the company’s plecanatide, branded as Trulance, for the treatment of chronic idiopathic constipation.
  • Intercept Pharmaceuticals Inc (NASDAQ: ICPT) dropped 4.1 percent to $109.95. Needham downgraded Intercept Pharmaceuticals from Buy to Hold.
  • Abraxas Petroleum Corp. (NASDAQ: AXAS) shares slipped 4.1 percent to $2.58. Abraxas Petroleum priced its 25 million share offering at $2.40 per share.
  • Herbalife Ltd. (NYSE: HLF) shares dropped 3.4 percent to $51.35. Herbalife issued disappointing earnings outlook for FY2017.
  • Stemline Therapeutics Inc (NASDAQ: STML) declined 3.2 percent to $10.65 after the company reported a proposed public offering of common stock.
  • Equifax Inc. (NYSE: EFX) slipped 2.2 percent to $117.54. Goldman Sachs downgraded Equifax from Neutral to Sell.
  • General Electric Company (NYSE: GE) shares fell 2.1 percent to $30.56. General Electric reported in-line earnings for its latest quarter, but sales missed expectations.

Latest Ratings for PSTI

Date Firm Action From To
Jul 2016 H.C. Wainwright Assumes Buy
Sep 2014 Jefferies Maintains Hold
Sep 2013 Maxim Group Upgrades Hold Buy

View More Analyst Ratings for PSTI
View the Latest Analyst Ratings



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today